Assertio Therapeutics Inc (ASRT) Insider Trading
- $384,241.46
- $5,424,667.78
- June 11, 2024
- Daniel A Peisert
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| June 11, 2024 | Director | 10,000 | $1.11 | Buy | $11,100.00 | |
| June 5, 2024 | Insider | 25,000 | $0.97 | Buy | $24,250.00 | |
| March 14, 2024 | Director | 10,251 | $1.12 | Sell | $11,481.12 | |
| Sept. 11, 2023 | CFO | 104,980 | $3.07 | Sell | $322,288.60 | |
| Sept. 11, 2023 | SVP | 45,236 | $3.04 | Sell | $137,517.44 | |
| Sept. 11, 2023 | CAO | 64,313 | $3.04 | Sell | $195,511.52 | |
| Sept. 11, 2023 | CEO | 127,281 | $3.04 | Sell | $386,934.24 | |
| Aug. 14, 2023 | Director | 22,000 | $3.14 | Sell | $69,080.00 | |
| May 19, 2023 | Director | 89,286 | $7.30 | Sell | $651,787.80 | |
| May 5, 2023 | Director | 43,143 | $6.00 | Sell | $258,858.00 | |
| May 12, 2022 | Director | 44,643 | $2.36 | Sell | $105,357.48 | |
| April 11, 2022 | CEO | 26,391 | $3.50 | Sell | $92,368.50 | |
| April 5, 2022 | CEO | 34,518 | $3.50 | Sell | $120,813.00 | |
| May 20, 2021 | CAO | 8,170 | $1.53 | Buy | $12,500.10 | |
| May 20, 2021 | CEO | 15,909 | $1.54 | Buy | $24,499.86 | |
| May 20, 2021 | CFO | 9,750 | $1.51 | Buy | $14,722.50 | |
| Dec. 23, 2020 | Major Shareholder | 6,784,334 | $0.37 | Sell | $2,510,203.58 | |
| Dec. 21, 2020 | Major Shareholder | 500,000 | $0.36 | Sell | $180,000.00 | |
| Dec. 18, 2020 | Major Shareholder | 500,000 | $0.38 | Sell | $190,000.00 | |
| May 8, 2020 | Director | 15,834 | $0.79 | Sell | $12,508.86 | |
| Nov. 12, 2019 | CEO | 25,000 | $0.73 | Buy | $18,250.00 | |
| Nov. 11, 2019 | CFO | 10,000 | $0.73 | Buy | $7,300.00 | |
| Nov. 11, 2019 | Director | 13,900 | $0.71 | Buy | $9,869.00 | |
| Aug. 20, 2019 | CFO | 14,000 | $1.50 | Buy | $21,000.00 | |
| Aug. 19, 2019 | Director | 25,000 | $1.61 | Buy | $40,250.00 | |
| Aug. 13, 2019 | SVP | 4,000 | $1.56 | Buy | $6,240.00 | |
| Aug. 12, 2019 | CFO | 19,000 | $1.57 | Buy | $29,830.00 | |
| Aug. 12, 2019 | Director | 50,000 | $1.54 | Buy | $77,000.00 | |
| June 13, 2019 | Director | 12,500 | $3.18 | Sell | $39,750.00 | |
| May 9, 2019 | Director | 12,500 | $4.70 | Sell | $58,750.00 | |
| March 14, 2019 | Director | 10,000 | $4.17 | Buy | $41,700.00 | |
| March 14, 2019 | CFO | 6,000 | $4.18 | Buy | $25,080.00 | |
| March 14, 2019 | SVP | 5,000 | $4.13 | Buy | $20,650.00 | |
| Dec. 14, 2018 | Director | 10,000 | $4.07 | Sell | $40,700.00 | |
| Dec. 3, 2018 | Director | 8,421 | $4.84 | Sell | $40,757.64 |
Insiders are both buying and selling Assertio Therapeutics Inc stock.
The insider traders at Assertio Therapeutics Inc are: Daniel A Peisert, Arthur J Higgins, William Mckee, Karen A Dawes, Group L.P. Cr, James L Tyree, Ajay Patel, Heather L Mason, Paul Schwichtenberg, Stan Bukofzer, Sam Schlessinger, Jeff L Vacirca, and Peter D Staple
The most active insider trader at Assertio Therapeutics Inc is Daniel A Peisert with 8 trades.
Group L.P. Cr has sold the most Assertio Therapeutics Inc stock with a total value of $5,390,407.16.
Arthur J Higgins has bought the most Assertio Therapeutics Inc stock with a total value of $195,450.00.
The most recent insider trade for Assertio Therapeutics Inc was on June 11, 2024.
The single biggest insider buy for Assertio Therapeutics Inc was from Arthur J Higgins with a total value of $77,000.00 on Aug. 12, 2019.
The single biggest insider sell for Assertio Therapeutics Inc was from Group L.P. Cr with a total value of $2,510,203.58 on Dec. 23, 2020.